FENC Stock Price
Fennec Pharmaceuticals Inc.
FENC stock price is $9.98 (-1.96% on the day), giving Fennec Pharmaceuticals Inc. a market cap of $356.56M. Below are the price chart, the MarketXLS Rank, the company profile and the latest news.
FENC Stock Overview
- Price
- $9.98
- Previous close
- $10.18
- Open
- $10.10
- Market cap
- $356.56M
- P/E ratio
- -36.6
- 52-week range
- $5.65 - $13.25
- 1-year price target
- $17.67
- Sector
- Healthcare
- Industry
- Biotechnology
- Exchange
- NSC
- MarketXLS Rank
- 40
About Fennec Pharmaceuticals Inc.
Fennec Pharmaceuticals Inc. operates as a commercial stage biopharmaceutical company in the United States. The company's product candidate includes PEDMARK, a formulation of sodium thiosulfate for the prevention of platinum-induced ototoxicity in pediatric cancer patients. It sells its products through regional pediatric oncology specialists and medical science liaisons. The company was formerly known as Adherex Technologies Inc. and changed its name to Fennec Pharmaceuticals Inc. in September 2014. Fennec Pharmaceuticals Inc. was incorporated in 1996 and is based in Research Triangle Park, North Carolina.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | FENC | $9.98 | -2.0% | 207.58K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Fennec Pharmaceuticals Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW